Gastric emptying in hereditary transthyretin amyloidosis: The impact of autonomic neuropathy

Neurogastroenterology and Motility

Volumn 24, Issue 12, 2012, Pages

  Wixner, J ^a   Karling, P ^a   Rydh, A ^a   Hornsten R ^a   Wiklund, U ^a   Anan, I ^a   Suhr, O B ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloidosis; Autonomic nervous system disorders; Gastric emptying; Hereditary; Nutrition status; Transthyretin

Indexed keywords

ALBUMIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT SCINTISCANNING; HEART RATE VARIABILITY; HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITION; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH EMPTYING; SYMPATHETIC FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; AMYLOID NEUROPATHIES, FAMILIAL; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; GASTRIC EMPTYING; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING; YOUNG ADULT;

EID: 84870301422     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01991.x     Document Type: Article

References (42)

1. Olsson M, Hellman U, Planté-Bordeneuve V, Jonasson J, Lång K, Suhr OB. Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients. Clin Genet 2009; 75: 163-8.
2. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976; 590: 1-64.
3. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994; 235: 479-85.
4. Suhr OB, Svendsen IH, Andersson R, Danielsson A, Holmgren G, Ranlov PJ. Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med 2003; 254: 225-35.
5. Suhr O, Danielsson A, Rydh A, Nyhlin N, Hietala SO, Steen L. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci 1996; 41: 1909-14.
6. Grybäck P, Hermansson G, Lyrenäs E, Beckman KW, Jacobsson H, Hellström PM. Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trial. Eur J Nucl Med 2000; 27: 647-55.
7. Wiklund U, Hörnsten R, Olofsson B-O, Suhr OB. Cardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathy. Auton Neurosci 2010; 2: 124-30.
8. Weise F, Heydenreich F, Runge U. Contributions of sympathetic and vagal mechanisms to the genesis of heart rate fluctuations during orthostatic load: a spectral analysis. J Auton Nerv Syst 1987; 3: 127-34.
9. Linden D, Diehl RR. Comparison of standard autonomic tests and power spectral analysis in normal adults. Muscle Nerve 1996; 19: 556-62.
10. Hörnsten R, Suhr OB, Jensen SM, Wiklund U. Outcome of heart rate variability and ventricular late potentials after liver transplantation for familial amyloidotic polyneuropathy. Amyloid 2008; 15: 187-95.
11. Wiklund U, Hörnsten R, Karlsson M, Suhr OB, Jensen SM. Abnormal heart rate variability and subtle atrial arrhythmia in patients with familial amyloidotic polyneuropathy. Ann Noninvasive Electrocardiol 2008; 13: 249-56.
12. Woo MA, Stevenson WG, Moser DK, Trelease RB, Harper RM. Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J 1992; 123: 704-10.
13. Tulppo MP, Mäkikallio TH, Takala TE, Seppänen T, Huikuri HV. Quantitative beat-to-beat analysis of heart rate dynamics during exercise. Am J Physiol 1996; 2: H244-52.
14. Stein PK, Domitrovich PP, Huikuri HV, Kleiger RE. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol 2005; 16: 13-20.
15. Weimer LH. Autonomic testing: common techniques and clinical applications. Neurologist 2010; 16: 215-22.
16. Ducla-Soares J, Alves MM, Carvalho M, Póvoa P, Conceição I, Sales Luis ML. Correlation between clinical, electromyographic and dysautonomic evolution of familial amyloidotic polyneuropathy of the Portuguese type. Acta Neurol Scand 1994; 90: 266-9.
17. Chelimsky G, Wiznitzer M, Chelimsky TC. Vomiting and gastroparesis in thoracic myelopathy with pure sympathetic dysfunction. J Pediatr Gastroenterol Nutr 2004; 39: 426-30.
18. Kendall BJ, Chakravarti A, Kendall E, Soykan I, McCallum RW. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. Aliment Pharmacol Ther 1997; 11: 381-5.
19. Araki S, Yi S. Pathology of familial amyloidotic polyneuropathy with TTR met 30 in Kumamoto, Japan. Neuropathology 2000; 20(Suppl.): S47-51.
20. Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998; 5: 288-300.
21. Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 1987; 2: 129-39.
22. El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994; 35: 1413-8.
23. Anan I, El-Salhy M, Ando Y et al. Colonic endocrine cells in patients with familial amyloidotic polyneuropathy. J Intern Med 1999; 245: 469-73.
24. Nyhlin N, Anan I, El-Salhy M, Ando Y, Suhr OB. Endocrine cells in the upper gastrointestinal tract in relation to gastrointestinal dysfunction in patients with familial amyloidotic polyneuropathy. Amyloid 1999; 6: 192-8.
25. Yoshimatsu S, Ando Y, Terazaki H et al. Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30). J Intern Med 1998; 243: 65-72.
26. Anan I, El-Salhy M, Ando Y et al. Colonic enteric nervous system in patients with familial amyloidotic neuropathy. Acta Neuropathol 1999; 98: 48-54.
27. Anan I, El-salhy M, Ando Y, Terazaki H, Suhr OB. Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy. Acta Neuropathol 2001; 102: 227-32.
28. Lång K, Wikström L, Danielsson A, Tashima K, Suhr OB. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand. J Gastroenterol 2000; 35: 985-9.
29. Suhr OB, Anan I, Ahlström KR, Rydh A. Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met). Amyloid 2003; 10: 121-6.
30. Anan I, El-Salhy M, Nyhlin N, Suhr OB. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy. Transplantation 2000; 70: 794-9.
31. Murray CDR, Martin NM, Patterson M et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54: 1693-8.
32. Ejskjaer N, Vestergaard ET, Hellström PM et al. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther 2009; 29: 1179-87.
33. Ordög T. Interstitial cells of Cajal in diabetic gastroenteropathy. Neurogastroenterol Motil 2008; 20: 8-18.
34. Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5years. Gut 2010; 59: 1716-26.
35. Ejskjaer NT, Bradley JL, Buxton-Thomas MS et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 1999; 16: 488-95.
36. Matsunaga N, Anan I, Forsgren S et al. Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation. Acta Neuropathol 2002; 104: 441-7.
37. Ando Y, Yamashita T, Tanaka Y et al. Role of nitric oxide in the peripheral vessels of patients with familial amyloidotic polyneuropathy (FAP) type I. J Auton Nerv Syst 1994; 50: 79-85.
38. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) 2009; 70: 415-20.
39. Okamoto S, Wixner J, Obayashi K et al. Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients' survival. Liver Transpl 2009; 15: 1229-35.
40. Ascaso JF, Herreros B, Sanchiz V et al. Oesophageal motility disorders in type 1 diabetes mellitus and their relation to cardiovascular autonomic neuropathy. Neurogastroenterol Motil 2006; 18: 813-22.
41. Asakawa H, Onishi M, Hayashi I, Fukuda A, Tokunaga K. Comparison between coefficient of R-R interval variation and gastric emptying in type 2 diabetes mellitus patients. J Gastroenterol Hepatol 2005; 20: 1358-64.
42. Abell TL, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol 2008; 36: 44-54.